Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029893567> ?p ?o ?g. }
- W2029893567 endingPage "378" @default.
- W2029893567 startingPage "378" @default.
- W2029893567 abstract "Abstract Background: Human and dog invasive bladder cancers share similar attributes, such as pathologic changes, response to chemotherapy, and extremely poor prognosis. Via combinatorial chemistry approach, we previously identified a novel bladder cancer-specific ligand, PLZ4, that can specifically bind to both human and dog bladder cancer cells in vitro and in vivo. We also developed a micelle nanocarrier drug delivery system with multifunctional loading capacity. Here, we assessed whether the targeting micelles impregnated with PLZ4 on the surface could promote targeting efficacy against both human and dog bladder cancers for diagnostic imaging and therapeutic purposes. Materials and Methods: Micelle-building monomers (i.e., telodendrimers) were synthesized through conjugation of polyethylene glycol with cholic acid cluster at one end and PLZ4 at the other end, which then self-assembled in aqueous solution to form micelles. Near-infrared dye DiD and chemotherapeutic drugs (paclitaxel or daunorubicin) were co-loaded for the experiments. Cellular uptake and distribution of nanomicelles were evaluated by fluorescence intensity and high resolution topography, while drug delivery efficacy was monitored by cytotoxicity assay. Using orthotopic/xenograft mouse model generated from human clinical bladder cancer specimen or dog bladder cancer line, in vivo and ex vivo fluorescence imaging as well as efficacy study were performed. Results: Compared to non-targeting micelles, targeting PLZ4-decorated-micelles loaded with an imaging agent DiD and chemotherapeutic drugs were more efficient in dye delivery, and caused a comparable to higher degree of cytotoxicity with free drugs in bladder cancer cell lines. According to topography, targeting micelles tended to localize at the membrane, perinuclear, and nucleus. In vivo and ex vivo orthotopic xenograft studies showed that both targeting (14.3X of free dye, p<0.01) and non-targeting micelles (9.6X, p<0.01) rapidly accumulated at the tumor sites, while targeting micelles exhibited significantly higher efficiency in homing property than non-targeting micelles (p<0.05). Considerably higher DiD signal was microscopically observed in targeting group than non-targeting group as well as free dye group, but all exhibited similar blood vessel density. Our preliminary efficacy study also supported a better drug delivery efficiency using targeting micelle formulation than non-targeting micelles/free drug in mouse xenografts formed from human clinical bladder tumors. Conclusions: Targeting micelles impregnated with PLZ4 can selectively and efficiently target both human and dog bladder cancer cells and can be potentially developed as imaging and therapeutic agents in both human and veterinary medicine. Preclinical studies of targeting micelles can be performed in dogs with spontaneous bladder cancer before proceeding to human patients. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 378. doi:1538-7445.AM2012-378" @default.
- W2029893567 created "2016-06-24" @default.
- W2029893567 creator A5003144081 @default.
- W2029893567 creator A5006103049 @default.
- W2029893567 creator A5016546967 @default.
- W2029893567 creator A5016566536 @default.
- W2029893567 creator A5016678529 @default.
- W2029893567 creator A5017220491 @default.
- W2029893567 creator A5030896915 @default.
- W2029893567 creator A5080694061 @default.
- W2029893567 date "2012-04-01" @default.
- W2029893567 modified "2023-10-03" @default.
- W2029893567 title "Abstract 378: Multifunctional bladder cancer targeting micelle nanocarriers with both imaging and therapeutic potentials" @default.
- W2029893567 doi "https://doi.org/10.1158/1538-7445.am2012-378" @default.
- W2029893567 hasPublicationYear "2012" @default.
- W2029893567 type Work @default.
- W2029893567 sameAs 2029893567 @default.
- W2029893567 citedByCount "2" @default.
- W2029893567 countsByYear W20298935672016 @default.
- W2029893567 countsByYear W20298935672022 @default.
- W2029893567 crossrefType "journal-article" @default.
- W2029893567 hasAuthorship W2029893567A5003144081 @default.
- W2029893567 hasAuthorship W2029893567A5006103049 @default.
- W2029893567 hasAuthorship W2029893567A5016546967 @default.
- W2029893567 hasAuthorship W2029893567A5016566536 @default.
- W2029893567 hasAuthorship W2029893567A5016678529 @default.
- W2029893567 hasAuthorship W2029893567A5017220491 @default.
- W2029893567 hasAuthorship W2029893567A5030896915 @default.
- W2029893567 hasAuthorship W2029893567A5080694061 @default.
- W2029893567 hasConcept C109316439 @default.
- W2029893567 hasConcept C11268172 @default.
- W2029893567 hasConcept C121332964 @default.
- W2029893567 hasConcept C121608353 @default.
- W2029893567 hasConcept C126322002 @default.
- W2029893567 hasConcept C147789679 @default.
- W2029893567 hasConcept C150903083 @default.
- W2029893567 hasConcept C178790620 @default.
- W2029893567 hasConcept C18150654 @default.
- W2029893567 hasConcept C184651966 @default.
- W2029893567 hasConcept C185592680 @default.
- W2029893567 hasConcept C202751555 @default.
- W2029893567 hasConcept C207001950 @default.
- W2029893567 hasConcept C26291073 @default.
- W2029893567 hasConcept C2777292972 @default.
- W2029893567 hasConcept C2778172261 @default.
- W2029893567 hasConcept C2779820397 @default.
- W2029893567 hasConcept C2780035454 @default.
- W2029893567 hasConcept C2780352672 @default.
- W2029893567 hasConcept C502942594 @default.
- W2029893567 hasConcept C55493867 @default.
- W2029893567 hasConcept C57477423 @default.
- W2029893567 hasConcept C62520636 @default.
- W2029893567 hasConcept C71924100 @default.
- W2029893567 hasConcept C86803240 @default.
- W2029893567 hasConcept C91881484 @default.
- W2029893567 hasConcept C98274493 @default.
- W2029893567 hasConceptScore W2029893567C109316439 @default.
- W2029893567 hasConceptScore W2029893567C11268172 @default.
- W2029893567 hasConceptScore W2029893567C121332964 @default.
- W2029893567 hasConceptScore W2029893567C121608353 @default.
- W2029893567 hasConceptScore W2029893567C126322002 @default.
- W2029893567 hasConceptScore W2029893567C147789679 @default.
- W2029893567 hasConceptScore W2029893567C150903083 @default.
- W2029893567 hasConceptScore W2029893567C178790620 @default.
- W2029893567 hasConceptScore W2029893567C18150654 @default.
- W2029893567 hasConceptScore W2029893567C184651966 @default.
- W2029893567 hasConceptScore W2029893567C185592680 @default.
- W2029893567 hasConceptScore W2029893567C202751555 @default.
- W2029893567 hasConceptScore W2029893567C207001950 @default.
- W2029893567 hasConceptScore W2029893567C26291073 @default.
- W2029893567 hasConceptScore W2029893567C2777292972 @default.
- W2029893567 hasConceptScore W2029893567C2778172261 @default.
- W2029893567 hasConceptScore W2029893567C2779820397 @default.
- W2029893567 hasConceptScore W2029893567C2780035454 @default.
- W2029893567 hasConceptScore W2029893567C2780352672 @default.
- W2029893567 hasConceptScore W2029893567C502942594 @default.
- W2029893567 hasConceptScore W2029893567C55493867 @default.
- W2029893567 hasConceptScore W2029893567C57477423 @default.
- W2029893567 hasConceptScore W2029893567C62520636 @default.
- W2029893567 hasConceptScore W2029893567C71924100 @default.
- W2029893567 hasConceptScore W2029893567C86803240 @default.
- W2029893567 hasConceptScore W2029893567C91881484 @default.
- W2029893567 hasConceptScore W2029893567C98274493 @default.
- W2029893567 hasIssue "8_Supplement" @default.
- W2029893567 hasLocation W20298935671 @default.
- W2029893567 hasOpenAccess W2029893567 @default.
- W2029893567 hasPrimaryLocation W20298935671 @default.
- W2029893567 hasRelatedWork W1467899699 @default.
- W2029893567 hasRelatedWork W1991649944 @default.
- W2029893567 hasRelatedWork W2029893567 @default.
- W2029893567 hasRelatedWork W2085653144 @default.
- W2029893567 hasRelatedWork W2115253983 @default.
- W2029893567 hasRelatedWork W2328865954 @default.
- W2029893567 hasRelatedWork W2564139406 @default.
- W2029893567 hasRelatedWork W3021986263 @default.
- W2029893567 hasRelatedWork W3187065269 @default.
- W2029893567 hasRelatedWork W4281727383 @default.
- W2029893567 hasVolume "72" @default.